Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 5/2007

Content (7 Articles)

Original Paper

Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapy

Ulrich Wedding, Bernd Röhrig, Ludger Pientka, Klaus Höffken

Original Paper

Helicobacter pylori-secreting protein Tipα is a potent inducer of chemokine gene expressions in stomach cancer cells

Takashi Kuzuhara, Masami Suganuma, Miki Kurusu, Hirota Fujiki

Original Paper

Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer

Hans Christiansen, Bernhard Saile, Robert M. Hermann, Margret Rave-Fränk, Andrea Hille, Heinz Schmidberger, Clemens F. Hess, Giuliano Ramadori

Original Paper

Decreased expression of insulin-like growth factor binding protein 7 in human colorectal carcinoma is related to DNA methylation

Fei Ye, Yuan Chen, Thomas Knösel, Karsten Schlüns, Manuela Pacyna-Gengelbach, Nicole Deutschmann, Maode Lai, Iver Petersen

Original Paper

Effects of 2-methoxyestradiol on endometrial carcinoma xenografts

Li Li, Fengling Yu, Xiaohua Wu, Jianxin Cheng, Ulf Ulmsten, Xin Fu

Original Paper

Methylation profile in benign, borderline and malignant ovarian tumors

K. F. Tam, V. W. S. Liu, S. S. Liu, P. C. K. Tsang, A. N. Y. Cheung, A. M. W. Yip, H. Y. S. Ngan

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine